We describe an adult female patient diagnosed with spinal melanotic ependymoma. She underwent surgery with the aim of gross total resection, but only subtotal resection was possible. Therefore, the patient was re-evaluated 6 weeks following surgery. Radiotherapy was considered as further treatment. The diagnosis, clinical course, etiology and pathology are discussed on the basis of the current literature.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.prp.2019.03.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spontaneous globe rupture from an intraocular melanotic schwannoma.
Eur J Ophthalmol
November 2024
Department of Ophthalmology, SUNY Upstate Medical University, Syracuse, New York, USA.
Introduction: Melanotic schwannoma (MS) is a rare neoplasm composed of Schwann cells with melanosomes in various maturation stages. While MS is typically observed in spinal nerve roots or peripheral nerves, their involvement in intraocular structures is uncommon. Here, we present a case of spontaneous globe rupture as the presenting feature of intraocular extension of a MS.
View Article and Find Full Text PDFInterosseous Malignant Melanotic Nerve Sheath Tumor of the Sacrum Treated With an Innovative Reconstruction Technique.
Cureus
July 2024
Pediatric Neurosurgery Division, Department of Pediatric Surgery, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, SAU.
Intraosseous malignant melanotic nerve sheath tumors are extremely uncommon peripheral nerve sheath tumors that typically present with benign clinical and histopathological features but with more aggressive long-term behavior. These tumors commonly originate from the dorsal nerve roots, sympathetic chain, cranial nerves, and lumbar plexus but may be found throughout the body. It usually presents with gradual compressive symptoms over months to years, like the typical presentation of schwannomas.
View Article and Find Full Text PDFSpinal malignant melanotic nerve sheath tumor with atypical magnetic resonance imaging findings: A case report.
Surg Neurol Int
July 2024
Department of Neurosurgery, Shin-Kuki General Hospital, Kuki, Japan.
Article Synopsis
- - A 79-year-old man with back pain and neurological symptoms was found to have a rare malignant melanotic nerve sheath tumor (MMNST) on an MRI of his spine.
- - The MRI showed an unusual lesion at the T9-T10 level, which was surgically removed, confirming it as an MMNST, and no further treatment was needed after confirming no metastases.
- - One year post-surgery, there has been no recurrence of the tumor, indicating successful management of the condition.
Malignant melanotic schwannoma of the cervical spinal cord: a case report.
BMC Neurol
May 2024
Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Spinal cord malignant melanotic schwannoma (MMNST) is a rare central nervous system tumor that originates from the spinal cord or spinal myelin sheath cells and can produce melanin. This type of tumor is usually highly aggressive and malignant, with a poor prognosis. The clinical manifestations of spinal cord MMNST are mainly pain, paresthesia, muscle weakness, muscle atrophy, etc.
View Article and Find Full Text PDFDysregulation of innate immune signaling in animal models of spinal muscular atrophy.
BMC Biol
April 2024
Integrative Program for Biological and Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Background: Spinal muscular atrophy (SMA) is a devastating neuromuscular disease caused by hypomorphic loss of function in the survival motor neuron (SMN) protein. SMA presents across a broad spectrum of disease severity. Unfortunately, genetic models of intermediate SMA have been difficult to generate in vertebrates and are thus unable to address key aspects of disease etiology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!